Literature DB >> 23403418

Natural history of Yersinia pestis pneumonia in aerosol-challenged BALB/c mice.

Henry S Heine1, Lara Chuvala, Renaldo Riggins, Gregory Hurteau, Ryan Cirz, Robert Cass, Arnold Louie, G L Drusano.   

Abstract

After a relatively short untreated interval, pneumonic plague has a mortality approaching 100%. We employed a murine model of aerosol challenge with Yersinia pestis to investigate the early course of pneumonic plague in the lung, blood, and spleen. We fit a mathematical model to all data simultaneously. The model fit to the data was acceptable. The number of organisms in the lung at baseline was estimated to be 135 (median) or 1,184 (mean) CFU/g. The doubling time was estimated as 1.5 to 1.7 h. Between 1 and 12 h postexposure, counts declined, but they then increased by 24 h, a finding hypothesized to be due to innate immunity. The model predicted that innate immunity declined with a half-time of 3 to 3.8 h. The threshold for bacteremia was 6.4 × 10(4) to 1.52 × 10(6) CFU/g. By 42 to 48 h, stationary phase was obtained. Lung bacterial burdens exceeded 10 log CFU/g. Obviating early defenses allows for rapid amplification of Y. pestis in bacteremia, making the rapid course with high mortality understandable.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23403418      PMCID: PMC3632931          DOI: 10.1128/AAC.02504-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  The automated bioaerosol exposure system: preclinical platform development and a respiratory dosimetry application with nonhuman primates.

Authors:  Justin M Hartings; Chad J Roy
Journal:  J Pharmacol Toxicol Methods       Date:  2004 Jan-Feb       Impact factor: 1.950

Review 2.  Persister cells.

Authors:  Kim Lewis
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

3.  Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.

Authors:  Henry S Heine; Arnold Louie; Fritz Sorgel; Jennifer Bassett; Lynda Miller; Lawrence J Sullivan; Martina Kinzig-Schippers; George L Drusano
Journal:  J Infect Dis       Date:  2007-07-19       Impact factor: 5.226

Review 4.  Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis.

Authors:  Gloria I Viboud; James B Bliska
Journal:  Annu Rev Microbiol       Date:  2005       Impact factor: 15.500

5.  Measurement of the respiratory volumes of laboratory animals.

Authors:  A C GUYTON
Journal:  Am J Physiol       Date:  1947-07-01

6.  Transmission dynamics of primary pneumonic plague in the USA.

Authors:  A F Hinckley; B J Biggerstaff; K S Griffith; P S Mead
Journal:  Epidemiol Infect       Date:  2011-07-07       Impact factor: 2.451

Review 7.  The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells.

Authors:  G R Cornelis; H Wolf-Watz
Journal:  Mol Microbiol       Date:  1997-03       Impact factor: 3.501

8.  Antibiotic treatment of experimental pneumonic plague in mice.

Authors:  W R Byrne; S L Welkos; M L Pitt; K J Davis; R P Brueckner; J W Ezzell; G O Nelson; J R Vaccaro; L C Battersby; A M Friedlander
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

9.  Cat-transmitted fatal pneumonic plague in a person who traveled from Colorado to Arizona.

Authors:  J M Doll; P S Zeitz; P Ettestad; A L Bucholtz; T Davis; K Gage
Journal:  Am J Trop Med Hyg       Date:  1994-07       Impact factor: 2.345

10.  Biological warfare at the 1346 siege of Caffa.

Authors:  Mark Wheelis
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

  10 in total
  11 in total

1.  Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.

Authors:  Henry S Heine; Arnold Louie; Jeffrey J Adamovicz; Kei Amemiya; Randy L Fast; Lynda Miller; Steven M Opal; John Palardy; Nicolas A Parejo; Fritz Sörgel; Martina Kinzig-Schippers; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2014-03-31       Impact factor: 5.191

2.  Mouse models of aerosol-acquired tularemia caused by Francisella tularensis types A and B.

Authors:  David L Fritz; Marilyn J England; Lynda Miller; David M Waag
Journal:  Comp Med       Date:  2014-10       Impact factor: 0.982

3.  Remote monitoring of the progression of primary pneumonic plague in Brown Norway rats in high-capacity, high-containment housing.

Authors:  Eric A Coate; Andrew G Kocsis; Kristen N Peters; Paul E Anderson; Mark R Ellersieck; Deborah M Fine; Deborah M Anderson
Journal:  Pathog Dis       Date:  2014-05-16       Impact factor: 3.166

4.  Natural History of Francisella tularensis in Aerosol-Challenged BALB/c Mice.

Authors:  Henry S Heine; Lara Chuvala; Renaldo Riggins; Ryan Cirz; Robert Cass; Arnold Louie; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2016-01-11       Impact factor: 5.191

5.  A Recombinant Attenuated Yersinia pseudotuberculosis Vaccine Delivering a Y. pestis YopENt138-LcrV Fusion Elicits Broad Protection against Plague and Yersiniosis in Mice.

Authors:  Amit K Singh; Roy Curtiss; Wei Sun
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.609

Review 6.  Bacterial programming of host responses: coordination between type I interferon and cell death.

Authors:  Miqdad O Dhariwala; Deborah M Anderson
Journal:  Front Microbiol       Date:  2014-10-28       Impact factor: 5.640

7.  Inhaled Liposomal Ciprofloxacin Protects against a Lethal Infection in a Murine Model of Pneumonic Plague.

Authors:  Karleigh A Hamblin; Stuart J Armstrong; Kay B Barnes; Carwyn Davies; Thomas Laws; James D Blanchard; Sarah V Harding; Helen S Atkins
Journal:  Front Microbiol       Date:  2017-02-06       Impact factor: 5.640

8.  Validated Methods for Removing Select Agent Samples from Biosafety Level 3 Laboratories.

Authors:  Alexandria E Kesterson; John E Craig; Lara J Chuvala; Henry S Heine
Journal:  Emerg Infect Dis       Date:  2020-11       Impact factor: 6.883

9.  Treatment with Fluticasone Propionate Increases Antibiotic Efficacy during Treatment of Late-Stage Primary Pneumonic Plague.

Authors:  Samantha D Crane; Srijon K Banerjee; Roger D Pechous
Journal:  Antimicrob Agents Chemother       Date:  2021-11-15       Impact factor: 5.191

10.  Impact of Toll-Like Receptor-Specific Agonists on the Host Immune Response to the Yersinia pestis Plague rF1V Vaccine.

Authors:  Sergei Biryukov; Jennifer L Dankmeyer; Zain Shamsuddin; Ivan Velez; Nathaniel O Rill; Raysa Rosario-Acevedo; Christopher P Klimko; Jennifer L Shoe; Melissa Hunter; Michael D Ward; Lisa H Cazares; David P Fetterer; Joel A Bozue; Patricia L Worsham; Christopher K Cote; Kei Amemiya
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.